Myles David C. — SEC Form 4 filings
SEC reporting owner CIK 1831216. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-05 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 3 filings — 187,066 shares, $4,895,689 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 49,800 shares @ $27.60 ($1,374,480) in Olema Pharmaceuticals, Inc., filed 2026-01-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | CH. DISCOV. & NON-CLIN DEV OFF | 6 | — | 11 legs · 187,066 sh · $4,895,689 | 10 |
Form 4 filings — Myles David C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 106,250 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 10,000 @ $28.34 · Option exercise (M): 50,000 @ $4.87 · Sale (S): 49,800 @ $27.60 · Sale (S): 200 @ $28.49 · Option exercise (M): 50,000 @ $4.87 · Sale (S): 14,997 @ $28.60 · +3 more | EDGAR |
| 2025-12-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 1,225 @ $28.08 · Sale (S): 43,729 @ $30.40 · Sale (S): 6,046 @ $31.39 · Gift (G): 9,000 @ $0 | EDGAR |
| 2025-03-03 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 205,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 48,750 @ $0 · Sale (S): 12,452 @ $9.38 · Sale (S): 13,314 @ $8.66 · Sale (S): 300 @ $9.39 | EDGAR |
| 2024-02-05 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1831216 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →